PAVmed Inc.
PAVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $6 | $8 | $10 |
| % Growth | -16.7% | -25% | -20% | – |
| Cost of Goods Sold | $55 | $41 | $79 | $48 |
| Gross Profit | -$50 | -$35 | -$71 | -$38 |
| % Margin | -1,000% | -583.3% | -887.5% | -380% |
| R&D Expenses | $1,088 | $790 | $787 | $807 |
| G&A Expenses | $3,505 | $3,670 | $4,384 | $4,187 |
| SG&A Expenses | $3,706 | $3,890 | $4,631 | $4,342 |
| Sales & Mktg Exp. | $201 | $220 | $247 | $155 |
| Other Operating Expenses | $0 | $0 | -$43 | $0 |
| Operating Expenses | $4,794 | $4,680 | $5,375 | $5,149 |
| Operating Income | -$4,844 | -$4,715 | -$5,446 | -$5,187 |
| % Margin | -96,880% | -78,583.3% | -68,075% | -51,870% |
| Other Income/Exp. Net | -$1,167 | -$7,609 | $24,069 | $6,329 |
| Pre-Tax Income | -$6,011 | -$12,324 | $18,623 | $1,142 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,383 | -$11,921 | $18,968 | $1,431 |
| % Margin | -107,660% | -198,683.3% | 237,100% | 14,310% |
| EPS | -0.29 | -0.74 | 1.275 | 0.12 |
| % Growth | 60.8% | -158% | 960.9% | – |
| EPS Diluted | -0.29 | -0.74 | 0.337 | 0.12 |
| Weighted Avg Shares Out | 21,555 | 18,085 | 13,876 | 11,199 |
| Weighted Avg Shares Out Dil | 21,555 | 18,085 | 52,496 | 11,199 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $8 | $8 | $2 |
| Interest Expense | $8 | $4 | $4 | $7 |
| Depreciation & Amortization | $22 | $22 | $43 | $69 |
| EBITDA | -$5,981 | -$12,298 | $18,670 | $1,218 |
| % Margin | -119,620% | -204,966.7% | 233,375% | 12,180% |